Pictet Asset Management’s BridgeBio Pharma BBIO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $78.5M | Sell |
1,807,434
-282,834
| -14% | -$12.3M | 0.08% | 237 |
|
|
2025
Q1 | $72.4M | Buy |
2,090,268
+282,796
| +16% | +$9.8M | 0.08% | 245 |
|
|
2024
Q4 | $49.6M | Sell |
1,807,472
-995,585
| -36% | -$27.3M | 0.05% | 299 |
|
|
2024
Q3 | $71.1M | Buy |
2,803,057
+154,100
| +6% | +$3.91M | 0.08% | 246 |
|
|
2024
Q2 | $67.1M | Sell |
2,648,957
-283,472
| -10% | -$7.18M | 0.08% | 237 |
|
|
2024
Q1 | $90.6M | Buy |
2,932,429
+165,244
| +6% | +$5.11M | 0.1% | 222 |
|
|
2023
Q4 | $112M | Buy |
2,767,185
+27,163
| +1% | +$1.1M | 0.12% | 192 |
|
|
2023
Q3 | $72.3M | Buy |
+2,740,022
| New | +$72.3M | 0.09% | 230 |
|